HPR59 Targeted and Immunotherapies for Cancer - Reimbursement and Expenditure in a Single-Payer Healthcare System in Bulgaria
Jul 1, 2022, 00:00 AM
10.1016/j.jval.2022.04.985
https://www.valueinhealthjournal.com/article/S1098-3015(22)01186-X/fulltext
Section Title :
Section Order :
10893
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)01186-X&doi=10.1016/j.jval.2022.04.985